Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Should we treat hypercholesterolaemia in patients over 65?

× No keyword cloud information.

8 in total

1. The low fat/low cholesterol diet is ineffective.

Authors: L A Corr; M F Oliver
Journal: Eur Heart J Date: 1997-01 Impact factor: 29.983

Review 2. Retardation and arrest of progression or regression of coronary artery disease: a review.

Authors: J Vos; P J de Feyter; M L Simoons; J G Tijssen; J W Deckers
Journal: Prog Cardiovasc Dis Date: 1993 May-Jun Impact factor: 8.194

3. Lipid-lowering for prevention of coronary heart disease: what policy now?

Authors: I Ul Haq; L E Ramsay; D M Pickin; W W Yeo; P R Jackson; J N Payne
Journal: Clin Sci (Lond) Date: 1996-10 Impact factor: 6.124

4. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

Authors: F M Sacks; M A Pfeffer; L A Moye; J L Rouleau; J D Rutherford; T G Cole; L Brown; J W Warnica; J M Arnold; C C Wun; B R Davis; E Braunwald
Journal: N Engl J Med Date: 1996-10-03 Impact factor: 91.245

5. Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial.

Authors: D Waters; L Higginson; P Gladstone; B Kimball; M Le May; S J Boccuzzi; J Lespérance
Journal: Circulation Date: 1994-03 Impact factor: 29.690

6. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease.

Authors: C B Treasure; J L Klein; W S Weintraub; J D Talley; M E Stillabower; A S Kosinski; J Zhang; S J Boccuzzi; J C Cedarholm; R W Alexander
Journal: N Engl J Med Date: 1995-02-23 Impact factor: 91.245

7. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

Authors: J Shepherd; S M Cobbe; I Ford; C G Isles; A R Lorimer; P W MacFarlane; J H McKillop; C J Packard
Journal: N Engl J Med Date: 1995-11-16 Impact factor: 91.245

8. Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS).

Authors: J W Jukema; A V Bruschke; A J van Boven; J H Reiber; E T Bal; A H Zwinderman; H Jansen; G J Boerma; F M van Rappard; K I Lie
Journal: Circulation Date: 1995-05-15 Impact factor: 29.690

8 in total